603351 威尔药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.1597.3226.6387.5587.910
总资产报酬率 ROA (%)1.5155.0804.7765.8296.492
投入资产回报率 ROIC (%)1.6495.5835.3696.6536.769

边际利润分析
销售毛利率 (%)26.02427.40927.27728.24434.213
营业利润率 (%)12.38210.53610.19211.49016.155
息税前利润/营业总收入 (%)13.10311.73611.01012.08516.777
净利润/营业总收入 (%)10.1629.4408.5009.60813.646

收益指标分析
经营活动净收益/利润总额(%)97.41397.27393.740100.25988.807
价值变动净收益/利润总额(%)-0.1171.186-0.1011.89210.123
营业外收支净额/利润总额(%)-0.029-0.276-0.336-0.860-0.534

偿债能力分析
流动比率 (X)1.1741.0750.8111.0991.627
速动比率 (X)0.8190.7690.5260.7621.253
资产负债率 (%)28.87030.11230.66924.76420.579
带息债务/全部投入资本 (%)21.14722.16421.38012.150--
股东权益/带息债务 (%)363.744341.864359.061706.0021,101.383
股东权益/负债合计 (%)245.295230.891225.738303.217385.938
利息保障倍数 (X)18.0829.54812.91517.43623.702

营运能力分析
应收账款周转天数 (天)53.68452.79843.96334.5820.000
存货周转天数 (天)66.37672.02068.52261.9690.000